// App-Quantinova.ai

POS1236 (2021) : IMPACT OF COVID-19 ON INITIATION AND RENEWAL OF BIOTHERAPIES AND TARGETED SYNTHETIC TREATMENTS

Researchers

Presenter

  • P. Richette

Principal Investigators

  • M. Allez

  • V. Descamps

  • M. Maravic

Medical Centers

  • Lariboisiere Hospital, Rheumatology, France, France

  • Saint Louis Hospital APHP, Gastroenterology, Paris, France

  • Bichat Hospital, APHP, Hematology, Paris, France

  • IQVIA, Ai & Data engine, Courbevoie, France

  • IQVIA, Analytic solutions, Courbevoie, France

  • IQVIA, Real World Solutions, Courbevoie, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Coronavirus disease

Biomarkers

  • Janus kinase

Drug/Treatment

  • Hydroxychloroquine

  • Methotrexate

  • Abatacept

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved